Literature DB >> 28262468

Congenital myopathy with "corona" fibres, selective muscle atrophy, and craniosynostosis associated with novel recessive mutations in SCN4A.

Hernan D Gonorazky1, Christian R Marshall2, Maryam Al-Murshed3, Lili-Naz Hazrati3, Michael G Thor4, Michael G Hanna4, Roope Männikkö4, Peter N Ray5, Grace Yoon6.   

Abstract

We describe two brothers with lower facial weakness, highly arched palate, scaphocephaly due to synostosis of the sagittal and metopic sutures, axial hypotonia, proximal muscle weakness, and mild scoliosis. The muscle MRI of the younger sibling revealed a selective pattern of atrophy of the gluteus maximus, adductor magnus and soleus muscles. Muscle biopsy of the younger sibling revealed myofibres with internalized nuclei, myofibrillar disarray, and "corona" fibres. Both affected siblings were found to be compound heterozygous for c.3425G>A (p.Arg1142Gln) and c.1123T>C (p.Cys375Arg) mutations in SCN4A on exome sequencing, and the parents were confirmed carriers of one of the mutations. Electrophysiological characterization of the mutations revealed the Cys375Arg confers full and Arg1142Gln mild partial loss-of-function. Loss of function of the Nav1.4 channel leads to a decrement of the action potential and subsequent reduction of muscle contraction. The unusual muscle biopsy features suggest a more complex pathomechanism, and broaden the phenotype associated with SCN4A mutations.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Channelopathies; Congenital myopathy; Corona fibres; SCN4A

Mesh:

Substances:

Year:  2017        PMID: 28262468     DOI: 10.1016/j.nmd.2017.02.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  Homozygous C-terminal loss-of-function NaV1.4 variant in a patient with congenital myasthenic syndrome.

Authors:  Andoni Echaniz-Laguna; Valérie Biancalana; Aleksandra Nadaj-Pakleza; Emmanuel Fournier; Emma Matthews; Michael G Hanna; Roope Männikkö
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-06-02       Impact factor: 10.154

2.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

Review 3.  Update on Congenital Myopathies in Adulthood.

Authors:  George Konstantinos Papadimas; Sophia Xirou; Evangelia Kararizou; Constantinos Papadopoulos
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

4.  Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study.

Authors:  Roope Männikkö; Leonie Wong; David J Tester; Michael G Thor; Richa Sud; Dimitri M Kullmann; Mary G Sweeney; Costin Leu; Sanjay M Sisodiya; David R FitzPatrick; Margaret J Evans; Iona J M Jeffrey; Jacob Tfelt-Hansen; Marta C Cohen; Peter J Fleming; Amie Jaye; Michael A Simpson; Michael J Ackerman; Michael G Hanna; Elijah R Behr; Emma Matthews
Journal:  Lancet       Date:  2018-04-05       Impact factor: 79.321

5.  Homozygosity for SCN4A Arg1142Gln causes congenital myopathy with variable disease expression.

Authors:  Christine K Sloth; Federico Denti; Nicole Schmitt; Bo Hjorth Bentzen; Christina Fagerberg; John Vissing; David Gaist
Journal:  Neurol Genet       Date:  2018-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.